Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126547331 | 12654733 | 1 | I | 20160715 | 0 | 20160815 | 20160815 | DIR | 41.00 | YR | F | N | 135.00000 | LBS | 20160808 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126547331 | 12654733 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | 0 | SUSPENSION FOR INJECTION | TIW | ||||||||||
| 126547331 | 12654733 | 2 | SS | TOPAMAX | TOPIRAMATE | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 3 | C | TOPAMAX LEVEMIR FLEX TOUCH | 2 | 0 | |||||||||||||
| 126547331 | 12654733 | 5 | C | YAZ | DROSPIRENONEETHINYL ESTRADIOL | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 9 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 11 | C | AMITRIPTYLINE HCL | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 13 | C | ESCITALOPRAM OXALATE. | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 15 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 19 | C | ALIGN - PROBIOTIC SUPPLEMENT | 2 | 0 | |||||||||||||
| 126547331 | 12654733 | 21 | C | GINKGO BILOBA | GINKGO | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 23 | C | SUPER B-COMPLEX | 2 | 0 | |||||||||||||
| 126547331 | 12654733 | 25 | C | ADVIL | IBUPROFEN | 1 | 0 | ||||||||||||
| 126547331 | 12654733 | 27 | C | ALLERGY MEDICINE | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126547331 | 12654733 | 1 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126547331 | 12654733 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126547331 | 12654733 | Abnormal behaviour | |
| 126547331 | 12654733 | Compulsive shopping | |
| 126547331 | 12654733 | Delusion | |
| 126547331 | 12654733 | Infection | |
| 126547331 | 12654733 | Insomnia | |
| 126547331 | 12654733 | Judgement impaired | |
| 126547331 | 12654733 | Mania | |
| 126547331 | 12654733 | Nervousness | |
| 126547331 | 12654733 | Obsessive-compulsive disorder | |
| 126547331 | 12654733 | Ovarian cyst | |
| 126547331 | 12654733 | Paranoia | |
| 126547331 | 12654733 | Periarthritis | |
| 126547331 | 12654733 | Personality change | |
| 126547331 | 12654733 | Restlessness | |
| 126547331 | 12654733 | Speech disorder | |
| 126547331 | 12654733 | Tachyphrenia | |
| 126547331 | 12654733 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126547331 | 12654733 | 1 | 20160201 | 0 |